Analyst Activity – Needham & Company LLC Reiterates Hold on ResMed (NYSE:RMD)

ME Staff
-
0

Analyst Ratings For ResMed (NYSE:RMD)

Today, Needham & Company LLC reiterated its Hold rating on ResMed (NYSE:RMD).

Some recent analyst ratings include

  • 3/7/2018-Needham & Company LLC Reiterated Rating of Hold.
  • 1/23/2018-Northland Securities Upgrade from a “Under Perform ” rating to a ” Market Perform” rating.
  • 1/23/2018-Macquarie was Downgraded by analysts at Macquarie from a “Neutral ” rating to a ” Sell” rating.
  • 10/12/2017-Jefferies Group Reiterated Rating of Sell.

Dividend information for ResMed (NYSE:RMD)

ResMed (NYSE:RMD) pays an annual dividend of $1.40 with a yield of 1.46% and an average dividend growth of 8.70% based on a 3 Year Average..

Dividend History for ResMed (NYSE:RMD)

  • On 1/22/2018 ResMed announced a quarterly dividend of $0.35 0.0039467749210645% with an ex dividend date of 2/7/2018 which will be payable on 3/15/2018.
  • On 10/26/2017 ResMed announced a quarterly dividend of $0.35 1.66% with an ex dividend date of 11/8/2017 which will be payable on 12/14/2017.
  • On 8/2/2017 ResMed announced a quarterly dividend of $0.35 1.93% with an ex dividend date of 8/15/2017 which will be payable on 9/21/2017.
  • On 4/27/2017 ResMed announced a quarterly dividend of $0.33 1.94% with an ex dividend date of 5/9/2017 which will be payable on 6/15/2017.
  • On 1/23/2017 ResMed announced a quarterly dividend of $0.33 1.89% with an ex dividend date of 2/7/2017 which will be payable on 3/16/2017.
  • On 10/25/2016 ResMed announced a quarterly dividend of $0.33 2.18% with an ex dividend date of 11/8/2016 which will be payable on 12/15/2016.
  • On 7/28/2016 ResMed announced a quarterly dividend of $0.33 1.92% with an ex dividend date of 8/16/2016 which will be payable on 9/22/2016.

Recent Insider Trading Activity For ResMed (NYSE:RMD)
ResMed (NYSE:RMD) has insider ownership of 1.77% and institutional ownership of 61.61%.

  • On 3/1/2018 James Hollingshead, Insider, sold 600 with an average share price of $94.01 per share and the total transaction amounting to $56,406.00.
  • On 2/15/2018 Brett Sandercock, CFO, sold 2,000 with an average share price of $93.42 per share and the total transaction amounting to $186,840.00.
  • On 2/5/2018 David Pendarvis, Insider, sold 2,810 with an average share price of $96.03 per share and the total transaction amounting to $269,844.30.
  • On 2/1/2018 Brett Sandercock, CFO, sold 1,250 with an average share price of $100.13 per share and the total transaction amounting to $125,162.50.
  • On 2/1/2018 Richard Mchale, Insider, sold 2,000 with an average share price of $100.12 per share and the total transaction amounting to $200,240.00.
  • On 1/26/2018 John P Wareham, Director, sold 25,934 with an average share price of $102.25 per share and the total transaction amounting to $2,651,751.50.
  • On 1/24/2018 Ronald R Taylor, Director, sold 4,885 with an average share price of $99.71 per share and the total transaction amounting to $487,083.35.

Recent Trading Activity for ResMed (NYSE:RMD)
Shares of ResMed closed the previous trading session at 95.67 down -0.45 0.47% with 95.37999725341797 shares trading hands.